Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone and SAB378 in HIV-associated Painful Peripheral Neuropathy
NCT00723918Phase 2Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- Apr 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SAB378 in HIV-associated neuropathy, sponsored by Washington University School of Medicine. Planned start Apr 2009; status: withdrawn.
02
Drugs
SAB378
03
Conditions
HIV-associated neuropathy
Beyond the preview
Go deeper on NCT00723918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00723918.